Washington, D.C.—The U.S. food supply remains safe for both people and animals, the Food and Drug Administration (FDA) assured in an announcment on March 24. "There is no evidence of human or animal food or food packaging being associated with transmission of the coronavirus that causes COVID-19," said Frank Yiannas,...
Washington, D.C.—Following the March 18 announcements by the Food and Drug Administration (FDA) that it is prioritizing resources and only performing “for-cause inspections” during the COVID-19 crisis, the Natural Products Association (NPA) proposed a two-pronged public-private partnership approach to ensure the safety of the global dietary supplement supply chain. The...
Silver Spring, MD—FDA is reopening the comment period for last year’s CBD hearing. The hearing was intended to obtain scientific data and information about the safety, manufacturing, product quality, marketing, labeling, and sale of products containing cannabis or cannabis-derived compounds; the docket for public comment was supposed to close on...
Silver Spring, MD—The FDA and FTC issued warning letters to seven companies for selling fraudulent COVID-19 products, according to a press announcement from FDA. The warning letters are the first to be issued by FDA for unapproved products intended to prevent or treat the coronavirus. FDA, the release says, is...
Silver Spring, MD—FDA has released a statement regarding their work dealing with cannabidiol (CBD), emphasizing a focus on protecting public health and providing market clarity. FDA notes in their statement that, while CBD is available in a variety of products, the agency has recently updated the public on concerns about...
Silver Spring, MD—FDA has outlined a 2020 action plan to help advance the safety of leafy greens. FDA notes in their plan that leafy greens like romaine lettuce are safely consumed daily, but that the produce has often been implicated in outbreaks of foodborne illness—for instance, the recurring outbreaks of...
Washington, D.C.—The FDA failed to meet its deadline to provide a Congressionally mandated report on how it plans to regulate cannabidiol (CBD), according to a press release from the Natural Products Association (NPA). In last year’s spending bill, Congress instructed the FDA to adopt an enforcement discretion policy within 120...
Washington, D.C.—President Trump has requested $5 million dollars to regulate the cannabidiol (CBD) industry in the administration's new FY2021 budget, according to a press release from the Natural Products Association (NPA). The request would allow the FDA to “continue enforcing the law to protect patients and the public while also...
Washington, D.C.—The Natural Products Association urged the FDA to take action against nutritional supplements claiming to treat or prevent infection by the coronavirus, according to a press release. President and CEO of NPA Daniel Fabricant, Ph.D., wrote in the letter: "As you are aware, the Wuhan Coronavirus is a substantial...
Edgewood, NY—A contract manufacturer doing business as ABH Nature's Products, Inc., ABH Pharama, Inc., and Stocknutra.com, Inc. ("ABH") announced a nationwide recall of all lots of its dietary supplement products pursuant to a Consent Decree entered by the U.S. District Court for the Eastern District of New York. The massive...
